Correction: Castro et al. Stakeholders’ Understanding of European Medicine Agency’s COVID-19 Vaccine Information Materials in EU and Regional Contexts. Vaccines 2023, 11, 1616
Indiana Castro, Marie Van Tricht, Nicole Bonaccorso, Martina Sciortino, Juan Garcia Burgos, Claudio Costantino, Rosa Gonzalez-Quevedo
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVaccine Coverage and Hesitancy
The author would like to make the following correction to this publication [1].
In the original publication, the mandatory disclaimer required for all scientific publications authored by European Medicines Agency (EMA) staff was inadvertently omitted. The correct disclaimer is provided below and should be included immediately after the Conflict of Interest section:
“Disclaimer: The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the regulatory agency/agencies or organisations with which the authors are employed/affiliated.”
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Castro I. Van Tricht M. Bonaccorso N. Sciortino M. Garcia Burgos J. Costantino C. Gonzalez-Quevedo R. Stakeholders’ Understanding of European Medicine Agency’s COVID-19 Vaccine Information Materials in EU and Regional Contexts Vaccines 202311161610.3390/vaccines 1110161637897018 PMC 10610863 · doi ↗ · pubmed ↗